TY - JOUR
T1 - Prevalence and risk factors of fecal incontinence in women undergoing stress incontinence surgery
AU - Markland, Alayne D.
AU - Kraus, Stephen R.
AU - Richter, Holly E.
AU - Nager, Charles W.
AU - Kenton, Kimberly
AU - Kerr, Lindsey
AU - Xu, Yan
N1 - Funding Information:
This work was supported in part by cooperative agreements from the National Institute of Diabetes and Digestive and Kidney Diseases, with additional support from the National Institute of Child Health and Human Development and the Office of Research on Women’s Health, National Institutes of Health.
PY - 2007/12
Y1 - 2007/12
N2 - Objective: The objective of the study was to determine the prevalence and identify potential risk factors for monthly fecal incontinence (FI) in women presenting for stress urinary incontinence (UI) surgery. Study Design: From 655 women enrolled in the Stress Incontinence Surgical Treatment Efficacy Trial, baseline data were analyzed. FI was defined as occurring at least monthly. Independent variables included sociodemographics, health status and history, physical examination, and validated UI questionnaires. Multivariable logistic regression models compared women with FI with women with only UI. Results: Prevalence of monthly FI was 16%, 10% for liquid stool, and 6% for solid stool. In multivariable analysis, increased risk of FI was associated (odds ratio, 95% confidence interval) with decreased anal sphincter contraction (4.5, 2.0 to 10.4), perimenopausal status (2.4, 1.1 to 5.0), prior incontinence surgery/treatment (1.8, 1.1 to 2.9), and increased UI bother (1.1, 1.1 to 1.2). Conclusion: Women enrolled in a stress UI surgical trial have high rates of monthly FI and further evaluation of FI symptoms may be warranted.
AB - Objective: The objective of the study was to determine the prevalence and identify potential risk factors for monthly fecal incontinence (FI) in women presenting for stress urinary incontinence (UI) surgery. Study Design: From 655 women enrolled in the Stress Incontinence Surgical Treatment Efficacy Trial, baseline data were analyzed. FI was defined as occurring at least monthly. Independent variables included sociodemographics, health status and history, physical examination, and validated UI questionnaires. Multivariable logistic regression models compared women with FI with women with only UI. Results: Prevalence of monthly FI was 16%, 10% for liquid stool, and 6% for solid stool. In multivariable analysis, increased risk of FI was associated (odds ratio, 95% confidence interval) with decreased anal sphincter contraction (4.5, 2.0 to 10.4), perimenopausal status (2.4, 1.1 to 5.0), prior incontinence surgery/treatment (1.8, 1.1 to 2.9), and increased UI bother (1.1, 1.1 to 1.2). Conclusion: Women enrolled in a stress UI surgical trial have high rates of monthly FI and further evaluation of FI symptoms may be warranted.
KW - fecal incontinence
KW - risk factors
KW - stress urinary incontinence
UR - http://www.scopus.com/inward/record.url?scp=36448956882&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=36448956882&partnerID=8YFLogxK
U2 - 10.1016/j.ajog.2007.08.062
DO - 10.1016/j.ajog.2007.08.062
M3 - Article
C2 - 18060972
AN - SCOPUS:36448956882
SN - 0002-9378
VL - 197
SP - 662.e1-662.e7
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
IS - 6
ER -